Hypermethylation of Smad7 in CD4+ T cells is associated with the disease activity of rheumatoid arthritis

Abstract

DNA hypermethylation at the Smad7 promoter regions may cause a loss of Smad7 in CD4⁺ T cells of RA patients, which may contribute to the RA activity by disrupting the Th17/Treg balance.